CPhI Worldwide returns to Milan in 2021, as Italy is set for industry growth

CPhI Worldwide returns to Milan in 2021, as Italy is set for industry growth

CPhI Worldwide will be held next year in Milan for the first time in over a decade – following its postponement in 2020 due to COVID-19. CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market.

The event is scheduled for 31st August – 2nd September and returns at an apt moment, as the pharma industry in Italy is anticipated to be one of the main beneficiaries of geo-diverse sourcing strategies.

Italy is Europe’s largest producer and exporter of APIs – 85% are exported to North America, the EU and Japan[1] – and the 2020 CPhI Annual Report Survey indicates the country is well set for growth in 2021, as pharma looks for new manufacturing partners. The results show that Italy has improved its ‘growth ranking’ by 16% in a year – the largest rise of any country – with Western European API manufacturers predicted to be the ‘biggest beneficiaries of supply chain changes’ by some 47% of respondents.

To further empower the industry’s growth, CPhI Worldwide 2021 will implement a ‘hybrid event model’, featuring onsite exhibition and conference agenda, s well as online sessions and matchmaking. Offering further encouragement for the prospects of attendees, nearly two thirds (61%) of the industry foresees an improved ‘business outlook for pharma’ in 2021, with 67% ‘actively looking for new partners’.

CPhI Worldwide 2021 in Milan will feature all five co-located events; including P-MEC, FDF, ICSE, BioProduction and Innopack, with Informa’s AllSecure Standards implemented – providing the most robust at-event biosafety measures, spanning dozens of special health & safety protocols.

Orhan Caglayan, Brand Director at CPhI Worldwide/Informa said: “We are really excited to be hosting the 2021 event in Milan – Europe’s largest pharma manufacturing region – especially with Italy seeing the largest reputational and growth increases of any country in our recent executive survey. Pharma manufacturers here, and particularly ingredients producers, are widely expected to see sizable growth rates in 2021, with companies now actively looking to make new contacts, and implement multi-partner sourcing strategies. That’s why meeting new contacts at the event next year will be so important, as it will be the first time the global community has come back together.”

Caglayan added: “CPhI Worldwide is international pharma’s only true one-stop-hub for everything from equipment, generics and packaging through to biologics, ingredients and contract services. We believe that quality of life can be improved through attainable healthcare, delivered by more accessible and affordable medicines.  It is why over the last 30+ years we have built a platform to unite the specialist communities improving healthcare – and our role has never been more important as new supply chain partnerships are sought globally. We help accelerate pharma advancement by enabling attendees to meet with not just one or two, but hundreds of potential partners simultaneously. Nowhere else can you do this as well as at CPhI Worldwide and we cannot wait to welcome global pharma to Milan.”

References

[1] Italian Pharma Outlook, Tuesday 6th October at the CPhI Festival of Pharma